AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇼

IBUPROFEN in Zimbabwe

30 products registered with MCAZ 30 active

Brand / ProductReg. No.HolderStatusExpires
IBUPROFEN
TABLET, COATED; ORAL
2002/3.1/4067VARICHEM PHARMACEUTICALS (PVT) LTDactive22 Jun 2030
IBUPROFEN
TABLET, COATED; ORAL
2002/3.1/4066VARICHEM PHARMACEUTICALS (PVT) LTDactive22 Jun 2030
NUROFEN
TABLET, COATED; ORAL
90/3.1/2414RECKITT BENCKISSER PHARMACEUTICALS PTY LTDactive7 Apr 2030
NUROFEN EXPRESS
TABLET, COATED; ORAL
2018/3.1/5664RECKITT BENCKISSER PHARMACEUTICALS PTY LTDactive3 Sept 2029
NUROFEN FOR CHILDREN ORANGE
SUSPENSION; ORAL
2015/3.1/5025RECKITT BENCKISSER PHARMACEUTICALS PTY LTDactive3 Sept 2029
NUROFEN FOR CHILDREN STRAWBERRY
SUSPENSION; ORAL
2015/3.1/5024RECKITT BENCKISSER PHARMACEUTICALS PTY LTDactive3 Sept 2029
NOVAFEN GEL
GEL
2015/3.1/5063PHARMANOVA PVT LTDactive23 Apr 2029
NOVAFEN FOR CHILDREN
SUSPENSION
2016/3.1/5205PHARMANOVA PVT LTDactive23 Apr 2029
NUROFEN PERIOD PAIN
TABLET, COATED; ORAL
2019/3.1/5773RECKITT BENCKISSER PHARMACEUTICALS PTY LTDactive3 Mar 2029
NUROFEN EXPRESS 400MG LIQUID CAPSULES
CAPSULE; ORAL
2017/2.1/5472RECKITT BENCKISSER PHARMACEUTICALS PTY LTDactive28 Feb 2029
NUROFEN FOR CHILDREN STRAWBERRY 4% M/V
SUSPENSION; ORAL
2018/3.1/5674RECKITT BENCKISSER PHARMACEUTICALS PTY LTDactive28 Feb 2029
DEEP RELIEF
GEL
2023/3.1/6397MENTHOLATUM R.S.A PTY LTDactive22 May 2028
ASCEPRIB IV 600
SOLUTION; INFUSION
2024/3.1/6613ASCENDIS PHARMA (PTY) LTDactive31 Dec 2027
IBUPROFEN
TABLET, COATED; ORAL
89/3.1/2271DATLABS PRIVATE LIMITEDactive31 Dec 2027
IBUPROFEN
TABLET, COATED; ORAL
89/3.1/1807DATLABS PRIVATE LIMITEDactive31 Dec 2027
NUROFEN EXPRESS
TABLET, COATED; ORAL
2018/3.1/5665RECKITT BENCKISSER PHARMACEUTICALS PTY LTDactive31 Dec 2027
DOLEX
CAPSULE; ORAL
87/3.1/2123CAPS PVT LTDactive31 Dec 2027
DOLEX
CAPSULE; ORAL
87/3.1/2122CAPS PVT LTDactive31 Dec 2027
IBUPROFEN
SUSPENSION; ORAL
2002/3.1/4069VARICHEM PHARMACEUTICALS (PVT) LTDactive31 Dec 2027
GOFEN 400
CAPSULE; ORAL
2021/3.1/6120MEGA LIFESCIENCES PUBLIC COMPANY LIMITEDactive31 Dec 2027
IBUPROFEN
TABLET, COATED; ORAL
2004/3.1/4253FDC LIMITEDactive31 Dec 2027
IBUPROFEN
TABLET, COATED; ORAL
2004/3.1/4254FDC LIMITEDactive31 Dec 2027
IBUSPAN
TABLET, COATED; ORAL
2003/3.1/4156SM PHARMACEUTICALSactive31 Dec 2027
IBUSPAN
TABLET, COATED; ORAL
2003/3.1/4155SM PHARMACEUTICALSactive31 Dec 2027
BRUFEN
TABLET, COATED; ORAL
76/3.1/770ABBOTT LABORATORIES SA (PTY) LTDactive31 Dec 2027
BRUFEN
TABLET, COATED; ORAL
76/3.1/769ABBOTT LABORATORIES SA (PTY) LTDactive31 Dec 2027
IBUN
GEL
2021/3.1/6101LINCOLN PHARMACEUTICALS LIMITEDactive31 Dec 2027
IBUPROFEN
TABLET, COATED; ORAL
2000/3.1/3742BAL PHARMAactive31 Dec 2027
IBUPROFEN
TABLET, COATED; ORAL
95/3.1/3015REMEDICA LTDactive31 Dec 2027
ASCEPRIB IV 400
SOLUTION; INFUSION
2024/3.1/6612ASCENDIS PHARMA (PTY) LTDactive31 Dec 2027

IBUPROFENMCAZ Registration Details

MCAZ (Zimbabwe) has 30 registered products containing IBUPROFEN, of which 30 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track IBUPROFEN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.